Company: PFSA
Filing Date: 2025-10-29
Form Type: 424B3
Source: 0001213900-25-103174
Chunk: 235

Company: Profusa, Inc.
Filing Date: 2025-10-29
Form: 424B3
Chunk 235
---
5% of its capital stock, and including certain affiliates of its directors, and certain of its executive
officers. Pursuant to the Voting Agreement, certain holders of its preferred stock and common stock have agreed to vote their shares in
favor of the election of certain directors and specified transactions approved by the requisite number of the shares of its voting capital
stock held by investors party thereto. The Voting Agreement will terminate upon the closing of the merger.

Right of First Refusal and Co-Sale Agreement

In May 2018, Profusa entered
into an amended and restated right of first refusal and co-sale agreement (the “Co-Sale Agreement”) with certain
holders of its preferred stock and common stock, including certain holders of 5% of its capital stock, and including certain affiliates
of its directors, and certain of its executive officers. Pursuant to the Co-Sale Agreement, Profusa has a right of first refusal
in respect of certain sales of securities by certain holders of its capital stock. To the extent Profusa does not exercise such right
in full, certain holders of its preferred stock are granted certain rights of first refusal and co-sale in respect of such sales.
The Co-Sale Agreement will terminate upon the closing of the merger.

APAC Joint Venture Term Sheet

In July 2020, Profusa
entered into a Binding Term Sheet for APAC Joint Venture (the “Original Term Sheet”) with Carbis Bay Limited, BC hSensor Limited,
and Tasly (International) Healthcare Capital Company Limited (collectively, the “Investors”), pursuant to which Profusa and
the Investors are negotiating definitive transaction agreements for a joint venture (the “JV”) intended to commercialize Lumee
Glucose and Lumee Oxygen (collectively, the “Licensed Products”) in the Asia Pacific region, which includes Greater China
(which includes the People’s Republic of China (“China”), Hong Kong SAR, Macau SAR, Taiwan), South Korea, New Zealand,
Australia and the 10 ASEAN countries (Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand and Vietnam)
(together the “Asia Pacific Region”). Subsequently, on May 10, 2023, Profusa and the Investors entered into Amendment
Number One to Binding Term Sheet for APAC Joint Venture, which amended the Original Term Sheet (the Original Term Sheet, as so amended,
the “Term Sheet”). Pursuant to the Term Sheet, Profusa and the Investors intend for Prof